Institution statistics

FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE - Spain

Ranking results:

Past rankings:

2019
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
2018
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	700-800
2015
Criterium:	Position:
Overall Score:	400-500
Total Project Funding per Partner:	700-800
Total Number of Projects:	700-800
Networking Rank (Reputation):	> 1000
Partner Constancy:	600-700
Project Leadership Index:	200-300
2012
Criterium:	Position:
Overall Score:	900-1000
Networking Rank (Reputation):	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 41
As coordinator: 4
As participant: 23
Sole participant: 14
Coordinator / Participant Ratio: 0.17^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2020	321.865	0	321.865	2
2019	170.122	0	170.122	1
2018	644.486	0	644.486	4
2017	3.831.958	0	743.619	1
2016	158.122	1.999.960	2.158.082	1	1
2015	4.045.426	7.411.340	1.175.197	2	2
2014	352.176	0	352.176	1
2013	0	13.900.091	1.557.949		3
2012	3.512.185	18.340.793	1.835.438	3	4
2011	3.119.666	59.716.366	5.469.638	2	7
2010	241.761	30.059.334	1.018.973	1	6

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	9
KAROLINSKA INSTITUTE	6
MEDIZINISCHE UNIVERSITAET WIEN	5
UNIVERSITY COLLEGE LONDON	5
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM	4
DIAGENODE	4
INSTITUT CATALA DE LA SALUT	4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE	4
WEIZMANN INSTITUTE OF SCIENCE	4
ACADEMISCH ZIEKENHUIS GRONINGEN	3
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR	3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	3
INSTITUT CATALA D'ONCOLOGIA	3
KATHOLIEKE UNIVERSITEIT LEUVEN	3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV	3
STICHTING KATHOLIEKE UNIVERSITEIT	3
THE UNIVERSITY OF EDINBURGH	3
UNIVERSITA DEGLI STUDI DI TORINO	3
UNIVERSITAET DES SAARLANDES	3
UNIVERSITY OF HELSINKI	3
CELLZOME	2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	2
CONSIGLIO NAZIONALE DELLE RICERCHE	2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER	2
EBERHARD KARLS UNIVERSITAET TUEBINGEN	2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS	2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON	2
GOETEBORGS UNIVERSITET	2
ISTITUTO EUROPEO DI ONCOLOGIA	2
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI	2
KING'S COLLEGE LONDON	2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	2
LUNDS UNIVERSITET	2
MOSAIQUES DIAGNOSTICS	2
STENO DIABETES CENTER	2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS	2
THE BABRAHAM INSTITUTE	2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	2
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	2
THE UNIVERSITY OF LIVERPOOL	2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA	2
UNIVERSITE DE GENEVE	2
UNIVERSITE PARIS DESCARTES	2
UNIVERSITY OF GLASGOW	2
UNIVERSITY OF NEWCASTLE UPON TYNE	2
AARHUS UNIVERSITETSHOSPITAL SKEJBY	1
ACADEMISCH ZIEKENHUIS LEIDEN	1
AGENDIA NV	1
AGILENT TECHNOLOGIES OESTERREICH	1
ALMAC DIAGNOSTICS LIMITED	1
AMC MEDICAL RESEARCH BV	1
AMGEN	1
APPLIED RESEARCH USING OMIC SCIENCES SL	1
ARISTOTLE UNIVERSITY OF THESSALONIKI	1
ARTTIC IN BRUSSELS SPRL	1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	1
ASSOCIATION EUROPEENNE CONTRE LES LEUCODYSTROPHIES	1
AVANTEA	1
AVANTICELL SCIENCE	1
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO	1
AZIENDA OSPEDALIERA DI PADOVA	1
AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA	1
AZIENDA OSPEDALIERA SAN GIOVANNI BATTISTA DI TORINO	1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION	1
BATAVIA BIOSERVICES BV	1
BIOCOMUNICAT	1
BIOCRATES LIFE SCIENCES	1
BIOGAZELLE	1
BIOLUTION	1
BIOMAX INFORMATICS	1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING	1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	1
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST	1
CANCEROPOLE PACA	1
CELERA CORPORATION	1
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN	1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE	1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES	1
CESAR CENTRAL EUROPEAN SOCIETY FOR ANTICANCER DRUG RESEARCH EWIV	1
CHARITE UNIVERSITAETSMEDIZIN BERLIN	1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL	1
CLC BIO	1
CRUCELL HOLLAND B V	1
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG	1
DEUTSCHES KREBSFORSCHUNGSZENTRUM	1
DIGNA BIOTECH SL	1
DUBLIN CITY UNIVERSITY	1
EMERGENTEC BIODEVELOPMENT	1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	1
EURAM LIMITED	1
EUROPEAN CERVICAL CANCER ASOCIATION	1
EUROPEAN MOLECULAR BIOLOGY LABORATORY	1
EUROPEAN RESEARCH AND PROJECT OFFICE	1
EVOTEC SAS	1
FONDATION DU CENTRE PLURIDISCIPLINAIRE D'ONCOLOGIE	1
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA	1
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA	1
FORSCHUNGSVERBUND BERLIN EV	1
FRANCE EUROPE INNOVATION	1
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH	1

Constancy:

Total number of partners:312

Partner loyalty:
Frequent Partner: (> 2 projects): 78
Rare Partner: 234

Frequent / Rare Partner Ratio: 0.33

Diversity:

Subjects:

Subject:	No:
MEDICINE	11
HEALTH	11
LIFE SCIENCES	11
MEDICINE, HEALTH	11
MEDICAL BIOTECHNOLOGY	9
SCIENTIFIC RESEARCH	6
TRAINING	3
EDUCATION	3
INNOVATION	2
SOCIAL ASPECTS	2
INNOVATION, TECHNOLOGY TRANSFER	2
TECHNOLOGY TRANSFER	2
COOPERATION	1
COORDINATION, COOPERATION	1
COORDINATION	1
POLICIES	1
EMPLOYMENT ISSUES	1
BIOTECHNOLOGY	1

Diversity index:0.38

Categories:

Category:	No:
BIOLOGICAL SCIENCES	21
RTD HORIZONTAL TOPICS	8
SOCIAL AND ECONOMIC CONCERNS	5

Project overview:

Start date	Project	acronym	role	funding	partners
2020-09-01	Genetically modified organoids for genetic variant interpretation in colorectal cancer	Organ-VIP	coordinator	160.932	1
2020-03-31	Role of the SWI/SNF complex in the Androgen Receptor cistrome regulation	RegARcis	coordinator	160.932	1
2019-01-02	Identification of a novel function of lysosomes in mitosis for cancer therapy	M-Lysosomes	coordinator	170.122	1
2018-09-05	DNA MEthylation for HPV-related disease among women living with HIV	MEsHH	coordinator	158.122	1
2018-09-03	Human gut Microbiome, gene Expression and Colorectal Cancer: Assigning causal roles from a novel Mendelian randomization perspective.	MECoCaM	coordinator	158.122	1
2018-09-01	Activation of PI3K signalling in the pathogenesis of Vascular Anomalies	PI3K-VAs	coordinator	158.122	1
2018-04-01	Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX)	PORTAL	coordinator	170.122	1
2017-09-01	Targeting the metabolism-immune system connections in Cancer	META-CAN	coordinator	3.831.958	20
2016-10-01	Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity	PLEIO-RANK	participant	1.999.960	1
2016-03-01	Identification and Characterization of Cis-Regulatory ModuleDysfunction in Rett Syndrome with ROQ-WACh	ROQ-WACh	coordinator	158.122	1
2015-11-01	Deciphering PI3K biology in health and disease	Phd	coordinator	3.896.148	13
2015-10-01	Endoplasmic Reticulum Stress in Health and Disease	TRAIN-ERS	participant	3.628.757	12
2015-02-01	Development of a ncRNA DNA Methylation Kit for the Diagnosis of Cancer of Unknown Primary	EPICUP	coordinator	149.278	1
2015-01-01	Chromatin Dynamics in Development and Disease	Chromatin3D	participant	3.782.583	12
2014-04-23	Crosstalk between microRNAs and epigenetics in melanocyte differentiation: A new approach to unravel the complexity of melanoma progression and metastasis	EPIMIRMEL	coordinator	352.176	1
2013-09-01	Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves	TRANSLINK	participant	5.996.971	13
2013-03-01	Epigenetic Training Network - Innovative techniques and models to understand epigenetic regulation in the pathogenesis of common diseases	EPITRAIN	participant	3.816.548	6
2013-01-01	Vascular Endothelial interactionS and SpEciaLization	VESSEL	participant	4.086.572	9
2012-10-01	"User-driven Development of Statistical Methods for Experimental Planning, Data Gathering, and Integrative Analysis of Next Generation Sequencing, Proteomics and Metabolomics data"	STATEGRA	participant	5.998.575	11
2012-10-01	STRATEGY TO INHIBIT TGF-Beta IN LIVER DISEASE	IT-LIVER	coordinator	3.312.185	11
2012-04-01	ADenoViruses as novel clinical treatments	ADVance	participant	3.861.450	13
2012-03-01	The Role of the RPL11/p53 Checkpoint in the Development and Treatment of DBA	DBA-Checkpoints	coordinator	100.000	1
2012-01-01	Mechanisms of prevention of type 2 diabetes by lifestyle intervention in subjects with pre-diabetes or at high-risk for progression	DEXLIFE	participant	5.486.631	10
2012-01-01	Modulation of AMPA receptor properties by auxiliary subunits	MOAMAUX	coordinator	100.000	1
2012-01-01	Pathways common to brain development and ageing: defining strategies for preventive therapy and diagnostics	DEVELAGE	participant	2.994.137	9
2011-10-01	A BLUEPRINT of Haematopoietic Epigenomes	BLUEPRINT	participant	29.996.664	45
2011-09-01	Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe	HPV-AHEAD	participant	2.999.946	11
2011-05-01	Use of adoptive T cell transfer in combination with oncolytic adenoviruses for cancer treatment	Cancer therapies	participant	223.670	2
2011-04-01	Epigenetic Disruption of Non-Coding RNAs in Human Cancer	EPINORC	participant	2.497.240	1
2011-03-01	European collaborative project on Targeted therapy in renal cell cancer: genetic and tumor-related biomarkers for response and toxicity	EuroTARGET	participant	5.999.550	15
2011-02-01	Breaking Tolerance - Combination of Virotherapy and Immunotherapy for Cancer Treatment	Viral&Immune Therapy	coordinator	153.917	1
2011-01-01	Modelling and predicting sensitivity to targeted therapies in colorectal cancers	COLTHERES	participant	5.999.300	11
2011-01-01	Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis	CURELUNG	coordinator	2.965.749	11
2011-01-01	Systems Biology of Colorectal Cancer	SYSCOL	participant	11.999.996	11
2010-12-01	Development of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation	MABSOT	participant	5.929.064	10
2010-11-01	Genomic predictors and oncogenic drivers in hepatocellular carcinoma	HEPTROMIC	participant	2.999.478	10
2010-08-02	Assembly of a prostate cancer genome-wide molecular interactome for the identification of the key regulatory genes of malignant transformation and new targets for therapeutic intervention	PC interactome	coordinator	241.761	1
2010-07-01	Immunomodulatory Effects of Exercise in Type 1 Diabetes	IMMEEDIA	participant	399.600	5
2010-05-01	health-economic modelling of PREvention strategies for Hpv-related Diseases in European CounTries	PREHDICT	participant	2.963.532	13
2010-03-01	Therapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials	LeukoTreat	participant	5.978.126	25
2010-01-01	Systems biology towards novel chronic kidney disease diagnosis and treatment	SysKID	participant	11.789.534	29

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum